wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33899917-0E459B04-D6BA-4456-9D2C-DCA525732DF8
Q33899917-0E459B04-D6BA-4456-9D2C-DCA525732DF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33899917-0E459B04-D6BA-4456-9D2C-DCA525732DF8
Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: a 52-week phase II trial.
P2860
Q33899917-0E459B04-D6BA-4456-9D2C-DCA525732DF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33899917-0E459B04-D6BA-4456-9D2C-DCA525732DF8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4aa6f8ba25e196990e1c932356e7654e04f24e0d
P2860
Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.